Technetium-99m ciprofloxacin - Jubilant Life Sciences
Alternative Names: INFECTONLatest Information Update: 21 Aug 2019
At a glance
- Originator BTG; St. Bartholomews Hospital
- Developer DRAXIS Specialty Pharmaceuticals
- Class Cyclopropanes; Fluoroquinolones; Heavy metals; Imaging agents; Piperazines; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Infections
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 08 Jan 2008 Bristol-Myers Squibb Medical Imaging has been acquired by Avista Capital Partners, and is now known as Lantheus Medical Imaging
- 29 Mar 2006 Enrolment has been completed in phase II studies in patients with soft tissue infections and in patients with osteomyelitis; enrolment is near completion in a phase II study in patients with diabetic foot ulcer, and is underway in patients with equivocal appendicitis